CNO Financial: The Medicare Supplement Shift and the Power of Captive Distribution
Q2 2026 earnings surged 45% YoY on strong Med Sup and Worksite growth, driving an 8% raise to full-year EPS guidance.
CNO · Earnings Call · 2026-07-31
A Quarter that Confirms the Model
CNO Financial delivered a standout Q2 2026, with operating EPS of $1.26, up 45% year-over-year, and an 8% increase to full-year EPS guidance. The quarter showcases the company's unique position in the middle-income insurance market, as Medicare Supplement premiums grew 52% — the third consecutive quarter of >50% growth — while Worksite division life and health NAP grew 29%, including a 44% jump in life sales.
CNO delivered a very strong quarter and first half of the year. Operating earnings per diluted share were up 45% in the second quarter and up 43% year to date excluding significant items.
This is not a one-off. The company has now delivered 16 consecutive quarters of sales growth, and the driver is a deliberate strategic shift. As CEO Gary Bhojwani noted, “Our results benefit from the shift in consumer preferences away from Medicare Advantage and towards Medicare supplements.” — Gary Chandru Bhojwani, Chief Executive Officer · 2026-07-31 This trend has been building for over a year, with management consistently positioning the company as a neutral distributor of both Medicare products but with a clear operational preference for the supplemental product. The strong quarter validates that positioning.
Worksite: The Growth Engine
The Worksite division is emerging as a powerful growth engine. Life and health NAP hit a record, up 29%, with hospital indemnity up 33% and accident up 31%. New client NAP soared 84%, reflecting geographic expansion and deeper penetration of existing markets. The success is a testament to the captive distribution model, which now generates approximately 90% of Worksite insurance sales. Gary emphasized the consistency of execution: “No major strategic shift. No major changes to products... it is just the continued blocking and tackling.” — Gary Chandru Bhojwani, Chief Executive Officer · 2026-07-31 This is the same message the company has delivered over prior calls, but the results are compounding. In the prior quarter, management discussed geographic expansion as a key driver; now it is paying off in tangible sales growth.
The distribution moat extends to the annuity business. While competitors face an arms race from new entrants, CNO's captive agents focus on the middle-income market, often competing only with bank CDs. As Gary put it, “We sell our annuities only through captive distribution... our competition is a bank CD.” — Gary Chandru Bhojwani, Chief Executive Officer · 2026-07-31 Annuity collected premiums reached a record $536 million, up 3%, and account values grew 7%. This insulation is a key reason why Investment income continues to grow, up 8% year-over-year, with the new money rate at 6.16% — the 14th consecutive quarter above 6%.
Raising the Bar: Capital, ROE, and Guidance
Management raised full-year operating EPS guidance to $4.60-$4.80, an 8% midpoint increase, while narrowing the expense ratio and lowering the effective tax rate assumption. The improved outlook is supported by strong underwriting and a robust capital position. Consolidated RBC stands at 377%, and holdco liquidity is $233 million. The company returned $77 million to shareholders in the quarter, including $60 million in buybacks.
The path to higher ROE is also accelerating. Trailing twelve-month operating ROE reached 14.1% (13.1% ex items), and Paul McDonough stated, “Our 2026 operating return on equity is expected to exceed the 3-year target of 12% we had previously established for year-end 2027.” — Paul Harrington McDonough, Chief Financial Officer · 2026-07-31 This builds on the message from the prior quarter, where Gary had said, “Twelve percent is nothing more than a waypoint.” — Gary Bhojwani, Chief Executive Officer · 2026-05-01 Now management is signaling that they will not only beat the target early but aim for top-quartile ROE over time.
Operating margin reached 12.6% in the latest quarter (up 2.2pp y/y), reflecting strong insurance product margins and favorable expense leverage. This is consistent with the multi-quarter trend of improving profitability.
Risk Factors and the Road Ahead
While the quarter was exceptionally strong, some dynamics warrant attention. The Medicare Supplement favorable reserve release of ~$4 million was called out as a one-time item, and management expects expense normalization in the back half. The D2C life sales were down 9% due to a shift away from television advertising, but the company highlighted that non-TV channels now generate 72% of D2C life sales. This transition may cause quarterly volatility, but management remains confident in the long-term trajectory.
The company also discussed potential additional Bermuda reinsurance transactions, with excess capital built up over several years. This could provide a one-time boost to free cash flow, though details remain subject to regulatory approval. The stock is trading near its 52-week high (+26.7% over the last 90 days), and with a price-to-FCF of 5.6x and improved fundamentals, the market is starting to reward the consistency of execution.
In summary, CNO Financial is capitalizing on a powerful demographic trend—11,000 Americans turning 65 daily—and a distribution model that few can replicate. The shift to Medicare Supplement, coupled with Worksite momentum and disciplined capital management, is driving sustainable earnings growth and a brighter ROE path. As the company approaches its investor briefing in September, the story remains one of steady execution rather than dramatic pivot, making this a name to watch in the insurance sector.